MYDX to Present at the LD Micro Invitational Investor Conference

Company Expects Double-Digit Sequential Quarterly Growth in 2016 as it Approaches Profitability

LA JOLLA, CA / ACCESSWIRE / June 2, 2016 / MyDx, Inc. (OTCQB: MYDX), one of the fastest growing chemical detection companies and producer of the patented MyDx™ (My Diagnostic) product line, the first battery operated, handheld, chemical analyzer for consumers, today announced that it will be presenting at the 6th annual LD Micro Invitational on Wednesday, June 8, 2016 at 2:00 pm PST / 5:00 pm EST in Track 4. The conference will be held at the Luxe Sunset Bel Air Hotel in Los Angeles and will feature nearly 200 companies in the small-cap universe.

Daniel Yazbeck, Chairman and Chief Executive Officer of MyDx, Inc., will be presenting on behalf of MyDx, Inc. and conducting one-on-one meetings with retail and institutional investors throughout the three-day investor conference. For investors interested in arranging a one-on-one meeting with Mr. Yazbeck, it is highly encouraged to please contact Phillip Sugarman at psugarman@irpartnersinc.com or your respective LD Micro representative before all of the available meeting times are taken. Please note that for those investors that will not be able to attend the LD Micro conference, a separate “Investor/Analyst Day” will be held at the Company’s corporate headquarters in the coming weeks, at which point Mr. Yazbeck is expected to announce a number of new strategic initiatives that are designed to further enhance shareholder value.

“The initial stages of the commercialization of our chemical analyzer technology has humbled us in a process that ultimately exceeded our internal expectations as measured by revenues, number of units sold, geographic diversification and, perhaps most importantly, the industry’s excitement and widespread acceptance of our patented technology,” said Mr. Yazbeck. “We believe 2016 will be a breakthrough year for our employees, clients and shareholders as we approach profitability based on the increasing demand we are experiencing for CannaDx, our first product out of the lab and into full global commercialization.

“The achievement of positive earnings and substantial decrease in our long-term debt will provide us with the financial flexibility to grow both our existing CannaDx product line while investing in the launch and commercialization of our OrganaDx, AquaDx, and AeroDx sensor technologies, which will provide us with three completely new and high margin revenue channels in addressable markets. We are very excited to be delivering on all cylinders and to be able to share our progress with existing and potentially new investors at both the LD Micro conference as well as other investor conferences in the coming weeks,” concluded Mr. Yazbeck.

Investor Presentation to be Webcast Live

Please note the Company’s presentation will be webcast live by visiting the following link: http://wsw.com/webcast/ldmicro10/mydx. The webcast will also be archived for 90 days on the investor relations section of the Company’s website at http://ir.cdxlife.com/presentations.

You can view MyDx’s profile by visiting the following link: http://www.ldmicro.com/profile/mydx. Profiles of presenting companies have been provided by LD Micro and this press release was compliments of Accesswire.

About LD Micro

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into an event platform hosting several influential conferences annually (Invitational, Summit, and Main Event).

In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LDM will continue to provide valuable tools for the benefit of everyone in the small and microcap universe.

For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for additional information.

About MyDx, Inc.

MyDx, Inc. (OTCQB: MYDX) is a rapidly growing chemical detection and sensor technology company based in San Diego, California whose mission is to help people Trust & Verify™ what they put into their minds and bodies. The Company has successfully developed and recently launched MyDx, a patented, affordable portable analyzer that provides real-time chemical analysis and fits in the palm of consumers’ hands. The multi-use MyDx leverages over a decade of established electronic nose technology to measure chemicals of interest. It owns a substantial and growing intellectual property portfolio of patents covering its technology. With its Canna sensor proven and now entering into the commercialization stage, the Company is now focusing on the final development and launch of its three other applications to detect chemicals in food (OrganaDx™), water (AquaDx™) and air (AeroDx™). For additional information on MyDx, please visit www.cdxlife.com.

Forward-Looking Statements

This news release contains “forward-looking statements” as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this press release that are not statements of historical fact may be considered to be forward-looking statements. Words such as “may,” “will,” “expect,” “believe,” “anticipate,” “estimate,” “intends,” “goal,” “objective,” “seek,” “attempt,” or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at www.sec.gov.

Investor Contact:

Phillip Sugarman, Vice President, Investor Relations
Phone: 818-280-6800
psugarman@irpartnersinc.com

SOURCE: MyDx, Inc. via LD Micro

ReleaseID: 440668